Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Prepaid Assets: 2021-2024

Historic Prepaid Assets for Autolus Therapeutics (AUTL) over the last 4 years, with Dec 2024 value amounting to $67.3 million.

  • Autolus Therapeutics' Prepaid Assets rose 43.24% to $85.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.3 million, marking a year-over-year increase of 43.24%. This contributed to the annual value of $67.3 million for FY2024, which is 92.55% up from last year.
  • As of FY2024, Autolus Therapeutics' Prepaid Assets stood at $67.3 million, which was up 92.55% from $35.0 million recorded in FY2023.
  • In the past 5 years, Autolus Therapeutics' Prepaid Assets ranged from a high of $67.3 million in FY2024 and a low of $35.0 million during FY2023.
  • In the last 3 years, Autolus Therapeutics' Prepaid Assets had a median value of $43.0 million in 2022 and averaged $48.4 million.
  • As far as peak fluctuations go, Autolus Therapeutics' Prepaid Assets dropped by 18.70% in 2023, and later spiked by 92.55% in 2024.
  • Yearly analysis of 4 years shows Autolus Therapeutics' Prepaid Assets stood at $36.3 million in 2021, then rose by 18.56% to $43.0 million in 2022, then dropped by 18.70% to $35.0 million in 2023, then soared by 92.55% to $67.3 million in 2024.